Your browser doesn't support javascript.
loading
Nuclear-Cytoplasmic Transport Is a Therapeutic Target in Myelofibrosis.
Yan, Dongqing; Pomicter, Anthony D; Tantravahi, Srinivas; Mason, Clinton C; Senina, Anna V; Ahmann, Jonathan M; Wang, Qiang; Than, Hein; Patel, Ami B; Heaton, William L; Eiring, Anna M; Clair, Phillip M; Gantz, Kevin C; Redwine, Hannah M; Swierczek, Sabina I; Halverson, Brayden J; Baloglu, Erkan; Shacham, Sharon; Khorashad, Jamshid S; Kelley, Todd W; Salama, Mohamed E; Miles, Rodney R; Boucher, Kenneth M; Prchal, Josef T; O'Hare, Thomas; Deininger, Michael W.
Afiliação
  • Yan D; Huntsman Cancer Institute, The University of Utah, Salt Lake City, Utah.
  • Pomicter AD; Huntsman Cancer Institute, The University of Utah, Salt Lake City, Utah.
  • Tantravahi S; Huntsman Cancer Institute, The University of Utah, Salt Lake City, Utah.
  • Mason CC; Division of Hematology and Hematologic Malignancies, The University of Utah, Salt Lake City, Utah.
  • Senina AV; Department of Pediatrics, The University of Utah, Salt Lake City, Utah.
  • Ahmann JM; Huntsman Cancer Institute, The University of Utah, Salt Lake City, Utah.
  • Wang Q; Huntsman Cancer Institute, The University of Utah, Salt Lake City, Utah.
  • Than H; Huntsman Cancer Institute, The University of Utah, Salt Lake City, Utah.
  • Patel AB; Department of Hematology, Nanfang Hospital, Southern Medical University.
  • Heaton WL; Huntsman Cancer Institute, The University of Utah, Salt Lake City, Utah.
  • Eiring AM; Department of Haematology, Singapore General Hospital, Singapore.
  • Clair PM; Huntsman Cancer Institute, The University of Utah, Salt Lake City, Utah.
  • Gantz KC; Division of Hematology and Hematologic Malignancies, The University of Utah, Salt Lake City, Utah.
  • Redwine HM; Huntsman Cancer Institute, The University of Utah, Salt Lake City, Utah.
  • Swierczek SI; Huntsman Cancer Institute, The University of Utah, Salt Lake City, Utah.
  • Halverson BJ; Huntsman Cancer Institute, The University of Utah, Salt Lake City, Utah.
  • Baloglu E; Huntsman Cancer Institute, The University of Utah, Salt Lake City, Utah.
  • Shacham S; Huntsman Cancer Institute, The University of Utah, Salt Lake City, Utah.
  • Khorashad JS; Division of Hematology and Hematologic Malignancies, The University of Utah, Salt Lake City, Utah.
  • Kelley TW; Huntsman Cancer Institute, The University of Utah, Salt Lake City, Utah.
  • Salama ME; Karyopharm Therapeutics, Inc, Newton, Massachusetts.
  • Miles RR; Karyopharm Therapeutics, Inc, Newton, Massachusetts.
  • Boucher KM; Department of Cellular Pathology, Hammersmith Hospital, Imperial College Health Care NHS Trust, London, United Kingdom.
  • Prchal JT; Department of Pathology, The University of Utah, Salt Lake City, Utah.
  • O'Hare T; Department of Pathology, The University of Utah, Salt Lake City, Utah.
  • Deininger MW; Department of Pathology, The University of Utah, Salt Lake City, Utah.
Clin Cancer Res ; 25(7): 2323-2335, 2019 04 01.
Article em En | MEDLINE | ID: mdl-30563936

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Núcleo Celular / Citoplasma / Mielofibrose Primária Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Núcleo Celular / Citoplasma / Mielofibrose Primária Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article